×

Formulations of an LSD1 inhibitor

  • US 10,166,221 B2
  • Filed: 04/21/2017
  • Issued: 01/01/2019
  • Est. Priority Date: 04/22/2016
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical formulation in solid oral dosage form comprising:

  • (a) an inhibitor of LSD1 which is Compound 1 di-tosylate salt of the formula;

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×